Liviu Klein, MD, MS
Basic profileAdvanced Heart Failure and Transplant Cardiology
Liviu Klein is a Cardiology physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
505 Parnassus Ave
Room M-1178b, Box 0124
San Francisco, CA 941432204
Telephone
415-476-2143Provider last certified this registry record 14 Oct 2021.
Clinical trials
- A Silver Lining in the VAD Sky
Sponsor: University of California, San Francisco
- Tailored Drug Titration Using Artificial Intelligence
Sponsor: Optima Integrated Health
- Right Ventricular Pacing in Pulmonary Arterial Hypertension
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202576 payments$48,807openpaymentsdata.cms.gov ↗
- Edwards Lifesciences CorporationProgram year20259 payments
- ABIOMEDProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.3%Beta blocker8.6%Bisoprolol Fumarate39%Metoprolol Succinate27%Carvedilol22%Sotalol13%Part D<11 patientsAldosterone antagonist (MRA)8.1%Spironolactone89%Eplerenone11%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
18.3%SGLT2 inhibitor10%Jardiance83%Farxiga17%Part D<11 patientsProton pump inhibitor6.9%Pantoprazole Sodium39%Lansoprazole34%Omeprazole27%Part D≥13 patients+ 1 more class in this area
Blood & clotting
8.6%Vitamin K antagonist4.6%Warfarin Sodium100%Part D≥21 patientsFactor Xa inhibitor1.2%Eliquis100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”